Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: TEVA PHARMACEUTICALS USA, INC.
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-01-18 to 2023-01-24
Current total value of award: $763484.4
Description: 8509643040!ADENOVIRUS TYPE 4 A